REAL WORLD UTILIZATION OF INTERMITTENT ANDROGEN DEPRIVATION THERAPY (IADT) FOR CASTRATION SENSITIVE METASTATIC PROSTATE CANCER IN MANITOBA

Janzen Bryan; Penner Makoy; Ong Aldrich; Koul Rashmi; Bashir Bashir; Hunter William; Drachenberg Darrel; Saranchuk Jeff; Nayak Jasmir; Bucher Oliver; Kim Julian

首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >REAL WORLD UTILIZATION OF INTERMITTENT ANDROGEN DEPRIVATION THERAPY (IADT) FOR CASTRATION SENSITIVE METASTATIC PROSTATE CANCER IN MANITOBA

【24h】

REAL WORLD UTILIZATION OF INTERMITTENT ANDROGEN DEPRIVATION THERAPY (IADT) FOR CASTRATION SENSITIVE METASTATIC PROSTATE CANCER IN MANITOBA

机译：曼尼托巴阉膜阉割敏感转移前列腺癌的间歇性雄激素剥夺治疗（IADT）的真实利用

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology》 |2019年第2019期|共2页
作者
Janzen Bryan; Penner Makoy; Ong Aldrich; Koul Rashmi; Bashir Bashir; Hunter William; Drachenberg Darrel; Saranchuk Jeff; Nayak Jasmir; Bucher Oliver; Kim Julian;
展开▼
作者单位

Univ Manitoba Winnipeg MB Canada;

Canadian Mennonite Univ Winnipeg MB Canada;

Univ Manitoba Winnipeg MB Canada;

Univ Manitoba Winnipeg MB Canada;

Univ Manitoba Winnipeg MB Canada;

Univ Manitoba Winnipeg MB Canada;

Univ Manitoba Winnipeg MB Canada;

Univ Manitoba Winnipeg MB Canada;

Univ Manitoba Winnipeg MB Canada;

Univ Manitoba Winnipeg MB Canada;

Univ Manitoba Winnipeg MB Canada;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. REAL WORLD UTILIZATION OF INTERMITTENT ANDROGEN DEPRIVATION THERAPY (IADT) FOR CASTRATION SENSITIVE METASTATIC PROSTATE CANCER IN MANITOBA [J] . Janzen Bryan, Penner Makoy, Ong Aldrich, Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology . 2019,第期

机译：曼尼托巴阉膜阉割敏感转移前列腺癌的间歇性雄激素剥夺治疗（IADT）的真实利用
2. Chemotherapy at First Diagnosis of Advanced Prostate Cancer - Revolution or Evolution? Findings from a British Uro-oncology Group UK Survey to Evaluate Oncologists' Views on First-line Docetaxel in Combination with Androgen Deprivation Therapy in Castrate-sensitive Metastatic and High-risk/Locally Advanced Prostate Cancer [J] . Davda R., Hughes S., Jones R., Clinical oncology . 2016,第6期

机译：在第一次诊断晚期前列腺癌的化疗 - 革命还是演变？英国Uro-Moycology Group Group US调查的调查结果评估肿瘤学系的肿瘤学家的看法与雄激素剥夺的转移和高风险/局部晚期前列腺癌的雄激素剥夺治疗组合
3. Re: Liselotte MS Boeve, Maarten CCM Hulshof, Andre N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019; 75: 410-8 Future Steps for Definitive Therapy in Metastatic Prostate Cancer: Lessons from the HORRAD Trial [J] . Shinde Ashwin, Li Richard, Amini Arya, European urology . 2019,第3期

机译：Re：Liselotte Ms Boeve，Maarten CCM Hulshof，Andre N. Vis等人。与雄激素剥夺治疗相比，对雄激素剥夺治疗的生存对雄激素剥夺治疗与前瞻性随机临床试验中原发性骨转移前列腺癌前列腺患者的同时剥夺治疗的影响：来自血腥审判的数据。 EUR UROL 2019; 75：410-8转移性前列腺癌中的明确治疗的未来步骤：来自血轮试验的教训
4. Serum levels of sex hormones before and after androgen deprivation therapy in Japanese prostate cancer patients [C] . A. Komiya, K. Ichimatsu, A. Morii, International Congress of Andrology . 2009

机译：日本前列腺癌患者中雄激素剥夺治疗前后的性激素血清水平
5. Muscle Cross-Sectional Area Is Improved and Physical Funciton Is Maintained After Home-Based Exercise in Men with Metastatic Castration-Resistant Prostate Cancer Undergoing Androgen Deprivation Therapy [D] . Alzer, Mohamdod Saber. 2020

机译：改善肌横截面积，并且在具有转移阉割的前列腺癌接受雄激素剥夺治疗的男性中的男性锻炼之后，将物理静脉凝集维持
6. Clinical outcomes of First-line Abiraterone Acetate (AA) or Enzalutamide (E) for Metastatic Castration-Resistant Prostate Cancer (mCRPC) after Androgen Deprivation Therapy (ADT) + Docetaxel (D) or ADT alone for Metastatic Hormone Sensitive Prostate Cancer (mHSPC) [O] . Edoardo Francini, Steven Yip, Shubidito Ahmed, -1

机译：一线醋酸阿比特龙（AA）或恩扎鲁胺（E）用于雄激素剥夺疗法（ADT）+多西他赛（D）或仅ADT用于转移性激素敏感性前列腺癌（mHSPC）的转移性去势抵抗性前列腺癌（mCRPC）的临床结果
7. Chemotherapy at first diagnosis of advanced prostate cancer – revolution or evolution? Findings from a British uro-oncology group UK survey to evaluate oncologists' views on first-line docetaxel in combination with androgen deprivation therapy in castrate-sensitive metastatic and high-risk/locally advanced prostate cancer [O] . Davda, R., Hughes, S., Jones, R., 2016

机译：首次诊断为晚期前列腺癌的化疗 - 革命还是进化？来自英国尿液肿瘤学组英国调查的结果，评估肿瘤学家对一线多西紫杉醇联合雄激素剥夺治疗对去势敏感的转移性和高风险/局部晚期前列腺癌的看法

REAL WORLD UTILIZATION OF INTERMITTENT ANDROGEN DEPRIVATION THERAPY (IADT) FOR CASTRATION SENSITIVE METASTATIC PROSTATE CANCER IN MANITOBA

著录项

相似文献

相关主题

期刊订阅